Michael Penney | People | Arnold & Porter

Mike Penney is co-head of Arnold & Porter's Capital Markets, Corporate Governance, and SEC Reporting practice. Mike advises on a full range of securities and corporate matters, including equity and debt offerings, M&A, joint ventures, venture capital and growth equity financings, and SEC reporting and compliance, primarily for clients in the technology, biotechnology, and financial services industries. His clients include: U.S.-based public issuers and foreign private issuers ranging from smaller reporting companies to well-seasoned issuers; investment banks and financial institutions; venture capital and private equity funds; and private companies in venture and growth equity financings.

Prior to joining the firm, Mike served as General Counsel of Hercules Capital, a public BDC focused on investments in venture-backed and publicly traded life sciences and technology companies.

Mike previously served as Vice President and Senior Counsel at State Street Corporation, where he led domestic and cross-border mergers and acquisitions, joint ventures and strategic investment transactions and capital raising transactions.

Focus Areas

Experience

Pharmacosmos on its $400 million tender offer and acquisition of G1 Therapeutics.
Coherus on its all-stock acquisition of Sufrace Oncology.
Enovix Corporation in its $100 million common stock primary offering, in its $250 million issuance of publicly-traded warrants and in its $350 million Rule 144A convertible notes offering, as well as on U.S. securities matters and mergers and acquisitions matters.
Enphase Energy in multiple offerings of convertible senior notes, including its $1.13 billion convertible notes offering, and in its acquisitions of Clipper Creek, DIN Engineering, and Sofdesk.
FTC Solar on U.S. securities matters, capital markets matters, and mergers and acquisitions matters.

SunPower in its offerings of Rule 144A convertible bonds, its at-the-market offering facility, and its acquisitions of Sunder Energy and Ambia Energy.